PTJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


PHYS THER
Vol. 88, No. 10, October 2008, pp. 1177-1185
DOI: 10.2522/ptj.20080043

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ptj.20080043v1
88/10/1177    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Rapid Responses are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sylvestre, J.-P.
Right arrow Articles by Delgado-Charro, M B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sylvestre, J.-P.
Right arrow Articles by Delgado-Charro, M B.
Related Collections
Right arrow Electrotherapy
Right arrow Pharmacology
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Research Reports

In Vitro Optimization of Dexamethasone Phosphate Delivery by Iontophoresis

Jean-Philippe Sylvestre, Richard H Guy and M Begoña Delgado-Charro

JP Sylvestre, PhD, is Postdoctoral Researcher, Department of Pharmacy and Pharmacology, University of Bath, Claverton Down, Bath, United Kingdom
RH Guy, PhD, is Professor, Department of Pharmacy and Pharmacology, University of Bath, Claverton Down, Bath, BA2 7AY, United Kingdom
MB Delgado-Charro, PhD, is Lecturer in Pharmaceutical Sciences, Department of Pharmacy and Pharmacology, University of Bath

Address all correspondence to Dr Guy at: r.h.guy{at}bath.ac.uk

Background and Purpose: This study was designed to evaluate the effects of competing ions and electroosmosis on the transdermal iontophoresis of dexamethasone phosphate (Dex-Phos) and to identify the optimal conditions for its delivery.

Methods: The experiments were performed using pig skin, in side-by-side diffusion cells (0.78 cm2), passing a constant current of 0.3 mA via Ag-AgCl electrodes. Dex-Phos transport was quantified for donor solutions (anodal and cathodal) containing different drug concentrations, with and without background electrolyte. Electrotransport of co-ion, citrate, and counterions Na+ and K+ also was quantified. The contribution of electroosmosis was evaluated by measuring the transport of the neutral marker (mannitol).

Results: Electromigration was the dominant mechanism of drug iontophoresis, and reduction in electroosmotic flow directed against the cathodic delivery of Dex-Phos did not improve drug delivery. The Dex-Phos flux from the cathode was found to be optimal (transport number of ~0.012) when background electrolyte was excluded from the formulation. In this case, transport of the drug is limited principally by the competition with counterions (mainly Na+ with a transport number of ~0.8) and the mobility of the drug in the membrane.

Discussion and Conclusion: Dex-Phos must be delivered from the cathode and formulated rationally, excluding mobile co-anions, to achieve optimal iontophoretic delivery.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
ptjournalHome page
F. B Underwood
Invited Commentary
Physical Therapy, October 1, 2008; 88(10): 1185 - 1187.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Physical Therapy Association.